Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
207.35
+10.11 (+5.13%)
Streaming Delayed Price
Updated: 1:25 PM EDT, Jul 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
815,162
Open
198.26
Bid (Size)
207.02 (100)
Ask (Size)
207.35 (100)
Prev. Close
197.24
Today's Range
194.67 - 207.35
52wk Range
121.05 - 219.72
Shares Outstanding
146,800,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biogen Appoints Michael J. Parini as Chief Legal Officer
July 15, 2026
From
Biogen Inc.
Via
GlobeNewswire
3 Reasons to Avoid BIIB and 1 Stock to Buy Instead
July 15, 2026
Biogen’s 14.4% return over the past six months has outpaced the S&P 500 by 6.2%, and its stock price has climbed to $192.84 per share. This was partly due to...
Via
StockStory
Topics
Stocks
Performance
YTD
+16.6%
+16.6%
1 Month
+4.4%
+4.4%
3 Month
+14.8%
+14.8%
6 Month
+22.5%
+22.5%
1 Year
+62.6%
+62.6%
More News
Read More
Discover which S&P500 stocks are making waves on Tuesday.
↗
July 14, 2026
Via
Chartmill
Biogen Backs Alzheimer’s Tau Drug for Phase 3 Despite Trial Miss
↗
July 14, 2026
Via
MarketBeat
These S&P500 stocks have an unusual volume in today's session
↗
July 14, 2026
Via
Chartmill
These S&P500 stocks are moving in today's session
↗
July 14, 2026
Via
Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks
↗
July 14, 2026
Via
Chartmill
Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease
July 14, 2026
From
Biogen Inc.
Via
GlobeNewswire
1 Mid-Cap Stock to Target This Week and 2 We Find Risky
July 14, 2026
Via
StockStory
Stock Market Today, July 13: Energy Stocks Cushion Dow as Tech Slides on Geopolitical Tensions
↗
July 13, 2026
Via
The Motley Fool
Topics
Economy
Stocks
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
July 10, 2026
Via
StockStory
2 Fast-Growing Pharmaceutical Stocks to Buy Now
↗
July 08, 2026
Via
The Motley Fool
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.
↗
July 04, 2026
Via
The Motley Fool
Topics
Intellectual Property
1 S&P 500 Stock with Promising Prospects and 2 We Question
July 02, 2026
Via
StockStory
Topics
Energy
Stocks
Block & Leviton LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Biogen, Inc. – BIIB
June 29, 2026
From
Block & Leviton LLP
Via
GlobeNewswire
Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen
June 29, 2026
From
Biogen Inc.
Via
GlobeNewswire
Why Biogen (BIIB) Stock Is Up Today
June 26, 2026
Via
StockStory
Topics
Artificial Intelligence
Earnings
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
June 23, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Therapeutics Stocks Q1 Recap: Benchmarking Biogen (NASDAQ:BIIB)
June 22, 2026
Via
StockStory
Topics
Artificial Intelligence
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials
June 22, 2026
Via
Investor Brand Network
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
June 22, 2026
Via
Investor Brand Network
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
June 22, 2026
From
BioMedWire
Via
GlobeNewswire
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
June 17, 2026
From
Biogen Inc.
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
June 16, 2026
From
Pomerantz LLP
Via
GlobeNewswire
3 Overrated Stocks Walking a Fine Line
June 15, 2026
Via
StockStory
Frequently Asked Questions
Is Biogen Idec publicly traded?
Yes, Biogen Idec is publicly traded.
What exchange does Biogen Idec trade on?
Biogen Idec trades on the Nasdaq Stock Market
What is the ticker symbol for Biogen Idec?
The ticker symbol for Biogen Idec is BIIB on the Nasdaq Stock Market
What is the current price of Biogen Idec?
The current price of Biogen Idec is 207.35
When was Biogen Idec last traded?
The last trade of Biogen Idec was at 07/16/26 01:25 PM ET
What is the market capitalization of Biogen Idec?
The market capitalization of Biogen Idec is 30.44B
How many shares of Biogen Idec are outstanding?
Biogen Idec has 30B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.